Assuntos
Aortite/etiologia , Sarcoidose/etiologia , Aneurisma da Aorta Torácica/etiologia , Aneurisma da Aorta Torácica/patologia , Aneurisma da Aorta Torácica/cirurgia , Aortite/patologia , Humanos , Masculino , Pessoa de Meia-Idade , Miocardite/etiologia , Miocardite/patologia , Sarcoidose/patologiaAssuntos
Cardiomiopatia Hipertrófica/complicações , Diabetes Mellitus Tipo 2/complicações , Cardiomiopatias Diabéticas/complicações , Aneurisma Cardíaco/cirurgia , Taquicardia Ventricular/complicações , Amiodarona/administração & dosagem , Antiarrítmicos/administração & dosagem , Criocirurgia/métodos , Feminino , Humanos , Pessoa de Meia-Idade , Recidiva , Taquicardia Ventricular/tratamento farmacológicoRESUMO
We present a case of ventricular tachycardia with clinical features suggestive of arrhythmogenic right ventricular cardiomyopathy. However, endomyocardial biopsy revealed non-caseating granulomas diagnostic of cardiac sarcoidosis.
Assuntos
Corticosteroides/administração & dosagem , Displasia Arritmogênica Ventricular Direita/diagnóstico , Miocárdio/patologia , Sarcoidose , Taquicardia Ventricular , Adulto , Antiarrítmicos/administração & dosagem , Displasia Arritmogênica Ventricular Direita/fisiopatologia , Biópsia , Desfibriladores Implantáveis , Diagnóstico Diferencial , Eletrocardiografia/métodos , Humanos , Linfonodos/diagnóstico por imagem , Masculino , Mediastino/diagnóstico por imagem , Prognóstico , Sarcoidose/complicações , Sarcoidose/diagnóstico , Sarcoidose/fisiopatologia , Sarcoidose/terapia , Sotalol/administração & dosagem , Taquicardia Ventricular/etiologia , Taquicardia Ventricular/fisiopatologia , Taquicardia Ventricular/terapia , Tomografia Computadorizada por Raios X/métodos , Função Ventricular/efeitos dos fármacosRESUMO
INTRODUCTION: Atrioventricular (AV) block is infrequently associated with QT prolongation and torsades de pointes (TdP). It was hypothesized that patients with AV block-mediated QT-related arrhythmia may have latent congenital long QT syndrome or a vulnerable genetic polymorphism. METHODS: Eleven patients with complete AV block and TdP were prospectively identified. Patients underwent assessment, resting electrocardiography and telemetry at baseline, during AV block and pre-TdP. Genetic testing of KCNH2, KCNQ1, KCNE1, KCNE2 and SCN5A was performed. Thirty-three patients with AV block without TdP were included for comparison. RESULTS: Genetic variants were identified in 36% of patients with AV block and TdP. Patients with AV block who developed TdP had significantly longer mean (+/- SD) corrected QT intervals (440+/-93 ms versus 376+/-40 ms, P=0.048) and Tpeak to Tend (Tp-Te) intervals (147+/-25 ms versus 94+/-25 ms, P=0.0001) than patients with AV block alone. In patients with a genetic variant, there was a significant increase in Tp-Te intervals at baseline, in AV block and pre-TdP compared with those who were genotype negative. A personal or family history of syncope or sudden death was more likely observed in patients with a genetic variant. CONCLUSIONS: TdP in the setting of AV block may be a marker of an underlying genetic predisposition to reduced repolarization reserve. The Tp-Te interval at baseline, in AV block and pre-TdP may predict a genetic mutation or polymorphism compromising repolarization reserve. Patients with TdP in the setting of AV block represent a phenotypic manifestation of latent congenital long QT syndrome.
Assuntos
Bloqueio Atrioventricular/genética , Bloqueio Atrioventricular/fisiopatologia , Eletrocardiografia , Torsades de Pointes/genética , Torsades de Pointes/fisiopatologia , Idoso , Morte Súbita , Canal de Potássio ERG1 , Canais de Potássio Éter-A-Go-Go/genética , Feminino , Predisposição Genética para Doença , Testes Genéticos , Genótipo , Humanos , Masculino , Proteínas Musculares/genética , Mutação , Canal de Sódio Disparado por Voltagem NAV1.5 , Polimorfismo Genético , Estudos Prospectivos , Canais de Sódio/genética , Síncope/genéticaRESUMO
The human Ether-a-go-go Related Gene (hERG) potassium channel plays a central role in regulating cardiac excitability and maintenance of normal cardiac rhythm. Mutations in hERG cause a third of all cases of congenital long QT syndrome, a disorder of cardiac repolarisation characterised by prolongation of the QT interval on the surface electrocardiogram, abnormal T waves, and a risk of sudden cardiac death due to ventricular arrhythmias. Additionally, the hERG channel protein is the molecular target for almost all drugs that cause the acquired form of long QT syndrome. Advances in understanding the structural basis of hERG gating, its traffic to the cell surface, and the molecular architecture involved in drug-block of hERG, are providing the foundation for rational treatment and prevention of hERG associated long QT syndrome. This review summarises the current knowledge of hERG function and dysfunction, and the areas of ongoing research.
Assuntos
Canais de Potássio Éter-A-Go-Go/genética , Canais de Potássio Éter-A-Go-Go/fisiologia , Síndrome do QT Longo/genética , Síndrome do QT Longo/fisiopatologia , Canal de Potássio ERG1 , Canais de Potássio Éter-A-Go-Go/química , Genótipo , Humanos , Ativação do Canal Iônico , Síndrome do QT Longo/tratamento farmacológico , Mutação , FenótipoRESUMO
Inherited mutations or drug-induced block of voltage-gated ion channels, including the human ether-à-go-go-related gene (HERG) K+ channel, are significant causes of malignant arrhythmias and sudden death. The fourth transmembrane domain (S4) of these channels contains multiple positive charges that move across the membrane electric field in response to changes in transmembrane voltage. In HERG K+ channels, the movement of the S4 domain across the transmembrane electric field is particularly slow. To examine the basis of the slow movement of the HERG S4 domain and specifically to probe the relationship between the S4 domain with the lipid bilayer and rest of the channel protein, we individually mutated each of the S4 amino acids in HERG (L524-L539) to tryptophan, and characterized the activation and deactivation properties of the mutant channels in Xenopus oocytes, using two-electrode voltage-clamp methods. Tryptophan has a large bulky hydrophobic sidechain and so should be tolerated at positions that interact with lipid, but not at positions involved in close protein-protein interactions. Significantly, we found that all S4 tryptophan mutants were functional. These data indicate that the S4 domain is loosely packed within the rest of the voltage sensor domain and is likely to be lipid exposed. Further, we identified residues K525, R528 and K538 as being the most important for slow activation of the channels.
Assuntos
Canais de Potássio Éter-A-Go-Go/química , Canais de Potássio Éter-A-Go-Go/fisiologia , Lipídeos/fisiologia , Mutagênese Sítio-Dirigida , Triptofano/genética , Sequência de Aminoácidos , Animais , Transporte Biológico Ativo , Canal de Potássio ERG1 , Eletroquímica , Canais de Potássio Éter-A-Go-Go/genética , Feminino , Humanos , Lipídeos/análise , Potenciais da Membrana/fisiologia , Modelos Biológicos , Dados de Sequência Molecular , Mutação , Oócitos/citologia , Oócitos/fisiologia , Técnicas de Patch-Clamp , Conformação Proteica , Estrutura Terciária de Proteína , Triptofano/fisiologia , Xenopus laevisRESUMO
The human ether-á-go-go related gene (HERG) encodes the pore forming alpha-subunit of the rapid delayed rectifier K(+) channel which is central to the repolarization phase of the cardiac action potential. HERG K(+) channels have unusual kinetics characterized by slow activation and deactivation, yet rapid inactivation. The fourth transmembrane domain (S4) of HERG, like other voltage-gated K(+) channels, contains multiple positive charges and is the voltage sensor for activation. In this study, we mutated each of the positively charged residues in this region to glutamine (Q), expressed the mutant and wild-type (WT) channels in Xenopus laevis oocytes and studied them using two-electrode voltage clamp methods. K525Q channels activated at more hyperpolarized potentials than WT, whereas all the other mutant channels activated at more depolarized potentials. All mutants except for R531Q also had a reduction in apparent gating charge associated with activation. Mutation of K525 to cysteine (C) resulted in a less dramatic phenotype than K525Q. The addition of the positively charged MTSET to K525C altered the phenotype to one more similar to K525Q than to WT. Therefore it is not charge per se, but the specific lysine side chain at position 525, that is crucial for stabilizing the closed state. When rates of activation and deactivation for WT and mutant channels were compared at equivalent total (chemical + electrostatic) driving forces, K525Q and R528Q accelerated activation but had no effect on deactivation, R531Q slowed activation and deactivation, R534Q accelerated activation but slowed deactivation and R537Q accelerated deactivation but had no effect on activation. The main conclusions we can draw from these data are that in WT channels K525 stabilizes the closed state, R531 stabilizes the open state and R534 participates in interactions that stabilize pre-open closed states.